SUMMARY
There is no consensus that hyperglycaemia is an independent predictor of morbidity-mortality in children. This retrospective observational study aimed to assess the association between abnormal perioperative glucose levels and adverse outcomes in infants receiving open-heart surgery with cardiopulmonary bypass. The records of a total of 233 infants who underwent cardiopulmonary bypass for a variety of congenital cardiac procedures between January and December 2010 were reviewed. The blood glucose levels, demographic and perioperative information were recorded. Patients who experienced complications (n=91) were compared with those who did not (n=142). We found both intraoperative and postoperative glucose levels increased compared to the preoperative values (P <0.001). Thirty patients (12.8%) experienced hyperglycaemia and 15 patients (6.4%) experienced at least one episode of hypoglycaemia during surgery. Within the first two days after surgery, 12 (5.2%) patients experienced hyperglycaemia and 32 (13.7%) became hypoglycaemic in the paediatric intensive care unit. However, the abnormal perioperative glucose levels were not associated with increased adverse outcomes. After adjusting for other potential variables, lower weight at surgery, longer surgery time and hospital length-of-stay are the independent predictors of morbidity-mortality. Our findings suggest that perioperative hyperglycaemia and mild transient hypoglycaemia do not appear to be detrimental to infants with congenital heart disease, although we did not assess neurological outcomes. Nevertheless, due to the limitations of the retrospective design of this study and its limited power, more thorough clinical randomised controlled trials are needed. unit (PICU) of a university-affiliated tertiary care children's hospital that is free-standing. The PICU has more than 2000 admissions every year with cardiac patients generally representing about 25% of this total. The Institutional Review Board approved this study (Approval No. 011/2011) and the need for informed consent was waived.
From January through to December 2010, 505 patients underwent open-heart surgery with CPB at the Children's Hospital of Chongqing Medical University and their medical records were reviewed. Patients were excluded if they met any of the following criteria: no CPB, more than one year old, non-cardiac structural anomalies, preoperative hepatic or renal dysfunction, preoperative steroid therapy, pre-existing diagnosis of diabetes mellitus or no perioperative glucose measurements.
Perioperative management
Food and milk were withheld six hours prior to surgery. No breast milk was allowed for four hours prior to surgery and no water was permitted for two hours prior to surgery.
Anaesthesia induction consisted of midazolam (0.1 mg/kg), cisatracurium besilate (0.15 mg/kg) and sufentanil (1 µg/kg). After tracheal intubation, invasive arterial and central venous catheters were placed. Anaesthesia was maintained with 1.0 minimum alveolar concentration of sevoflurane and a continuous intravenous infusion of sufentanil (2-4 µg/kg/h) and cisatracurium (0.1 mg/kg/h). CPB was performed with a STOCKERT-SC (Maschinen Stockert, GmbH, Hohenbrunn, Bavaria, Germany) cardiopulmonary bypass unit and a DIDECO (Sorin, Mirandola, Italy) hollow fibre oxygenator. During anaesthesia, the electrocardiogram, direct arterial pressure, central venous pressure, urine volume, nasopharyngeal temperature, rectal temperature, blood gas analysis, electrolytes, P ET CO 2 and haematocrit were monitored. No intraoperative glucose containing fluids, except blood products, were administered to patients. During CPB, the haematocrit was maintained between 21-27% and all infants were given methylprednisolone 15 mg/kg during surgery.
All patients were sent to the PICU immediately after surgery with a tracheal tube in situ. There was no formal glucose management protocol. Typically, neonates were maintained on a 10% dextrose solution and older children were maintained on a 5% dextrose solution until they were able to tolerate enteral feeding.
Definition of variables and outcomes
Demographic data (including gender, age, weight at surgery, gestational weeks, weight at birth, definite preoperative hereditary diseases, preoperative pneumonia and preoperative heart failure) were obtained by reviewing each patient's chart. Before surgery, a Ross score was used to estimate heart function 11 . If the scores were greater than three, heart failure existed 11 . All the infants were classified into risk categories according to the consensus-based method for risk adjustment for surgery for congenital heart disease (RACHS-1) 12 .
The operative data included duration of bypass, cross-clamp time, operating time, intraoperative blood products administered, mechanical ventilation time and PICU length-of-stay. Adverse outcomes were in-hospital complications including the following cardiovascular outcomes: malignant arrhythmias requiring anti-arrhythmia therapy or insertion of a temporary pacemaker, hydropericardium diagnosed by cardiac ultrasound needing treatment, postoperative heart failure (without preoperative heart failure, Ross scores of greater than three after surgery and treated with vasopressors) and pulmonary hypertension crisis diagnosed by clinicians (severe hypoxemia, severe hypotension, increased central venous pressure, tachycardia and metabolic acidosis). The non-cardiovascular complications included renal failure requiring dialysis, pleural effusion confirmed with colour Doppler ultrasonography and needing treatment, infection with a positive blood or tracheal secretion culture, shock diagnosed by clinicians and treated with vasopressors, prolonged intubation (>24 hours) and a prolonged PICU stay (>96 hours).
Blood glucose measurement
The blood glucose value measured immediately after anaesthesia induction was defined as the preoperative value. During surgery the arterial blood gas glucose levels were the intraoperative values. During the PICU stay, blood glucose was measured in the arterial blood samples every three to six hours at the discretion of the attending physician. During the first two postoperative days, glucose levels were identified in the record and the maximum, minimum and mean of all perioperative blood glucose values were obtained during the operating room and PICU stay.
Hyperglycaemia was defined as a mean glucose above 8.3 mmol/l. Hypoglycaemia was defined as a minimal glucose below 3.6 mmol/l.
Statistical analysis
Statistical analysis was performed with SPSS software (Version 17.0, Chicago, IL, USA). Continuous variables were expressed as a mean with one standard error and were compared using the Student's t-test after a normal distribution was confirmed by the Kolmogorov-Smirnov test. Continuous abnormal distribution variables were expressed as a median (25th-75th percentile) and compared using the Wilcoxon signed-rank test. Categorical variables were expressed as percentages and were evaluated with the Pearson chi-square test or the Fisher's exact test. We used a univariate analysis to identify clinical variables associated with adverse events. Factors with a P <0.05 and mean perioperative glucose were entered into a multiple logistic regression model to estimate their effect on clinically adverse outcomes, which were adjusted for potential confounders. Backward stepwise logistic regression analysis was conducted to identify risk factors of adverse events.
RESULTS
In the study period there were a total of 505 children enrolled but seven patients did not have CPB, 263 patients were more than one year old and data had been lost for two cases. So for analysis, there were 233 infants' data used. No patient received insulin therapy and no patient was given extra glucose intraoperatively. Patient demographic and operative characteristics are summarised in Table 1. A total of 142 patients reached the overall composite morbidity-mortality endpoint at some point during their postoperative PICU stay. Twenty-six infants experienced heart failure, including 20 infants (8.6%) who died from refractory cardiac failure before discharge, 15 patients (6.4%) who experienced a malignant arrhythmia which was defined as requiring anti-arrhythmia therapy or insertion of a temporary pacemaker, and four patients (1.7%) who suffered from hydropericardium. There was no case of pulmonary hypertension crisis. Sixty-seven patients (28.8%) needed mechanical ventilation support for more than 24 hours, 56 patients (24.0%) required a prolonged PICU stay (>96 hours), two patients (0.9%) developed renal failure and required dialysis, two patients (0.9%) went into shock, 31 patients (13.3%) had infection with positive blood or tracheal secretion culture and five patients (2.1%) experienced pleural effusion diagnosed by ultrasonography for which thoracocentesis was performed ( Table 2) .
According to our definition, 30 patients (12.9%) developed hyperglycaemia (>8.3 mmol/l) during surgery and 15 patients (6.4%) developed at least one episode of hypoglycaemia (<3.6 mmol/l). During the first two days after surgery in the PICU, 12 patients (5.2%) experienced hyperglycaemia and 32 patients (13.7%) experienced hypoglycaemia ( Table 3 ).
The preoperative mean of blood glucose values was 4.6±1.9 mmol/l and it rose to 6.8±1.5 mmol/l after CPB started. Thus, blood glucose values almost doubled and the difference was significant (P <0.01). Comparing this to the preoperative blood glucose values, the mean of postoperative blood glucose values also increased (P <0.01), but there was no significant difference between intraoperative and postoperative values (P=0.10).
Demographic data and operative variables were assessed by univariate analysis as potential risk factors for adverse outcome. With univariate analysis, only the following variables were associated with the overall composite morbidity-mortality endpoint: age, weight at surgery, weight at birth, duration of bypass, cross-clamp time, operating time and intraoperative total blood products administered ( Table 4 ). The infants in the complication group had a lower weight, both at surgery (P <0.01) and at birth (P=0.019), and they were younger than the patient in the no complications group (P <0.01). The patients with adverse outcomes had experienced longer duration of bypass, cross-clamp time, operating time and received more blood products during surgery (P <0.01). An overall analysis of the above possible risk factors and perioperative blood glucose values, using a stepwise logistic regression, identified that weight at surgery and operating time were significantly associated with the composite endpoint ( Table 5 ). The model fitted well and the Hosmer-Lemeshow test showed a P=0.60. The most interesting finding was that perioperative glucose level was not a significant predictor for morbidity. Using weight at surgery and operating time to predict complications was investigated by using a receiver operating characteristic curve analysis.
The area under the curve was comparable between the two predictors, 0.68 (95% confidence interval, 0.61-0.75) for weight at surgery and 0.76 (95% confidence interval, 0.70-0.82) for operating time, and showed a moderate predictive value for adverse events.
DISCUSSION
The perioperative management of blood glucose in children undergoing open-heart surgery has been the subject of more than two decades of controversy. In recent years the controversy has only increased. Despite the research in adults, it is still questionable as to whether hyperglycaemia has an association with adverse outcomes in children after cardiac surgery 6, [13] [14] [15] [16] [17] [18] . Some reports suggest perioperative hyperglycaemia is associated with adverse outcomes 13, [18] [19] , although in other studies hyperglycaemia was not a risk factor for infection, low cardiac output, other complication or death 6, [14] [15] [16] [17] . One recent study found that hypoglycaemia rather than hyperglycaemia was related to electroencephalographic seizures and slower electroencephalographic recovery 14 . In addition, some studies even found that euglycaemia was identified as a risk factor for poor outcomes, although their definitions of euglycaemia were different 6, 16 .
In this single-centre retrospective observational analysis, we found there was no relationship between high glucose concentrations (>8.3 mmol/l) and adverse outcomes. After adjusting for other potential risk factors, the independent risk factors indicate that morbidity-mortality was related to body weight at surgery and operating time. This negative result suggests TGC was not necessary in infants receiving open-heart surgery with CPB. However, the retrospective observational nature of our study and our limited power to detect the effects of hyperglycaemia/hypoglycaemia on outcomes must be considered when interpreting our results (i.e. there appeared to be differences in perioperative glucose levels between the no complication and complication groups, although these were not significant) (Table  3) . Also, we did not specifically assess neurological outcomes and so cannot comment on the effect of hyperglycaemia/hypoglycaemia on neurological outcomes. Another limitation is that blood glucose values are continuous and always changing, but our measurements were intermittent.
Unfortunately the information on TGC for openheart surgery children is extremely limited 20 . A prospective study indicated that both protocols of glycaemic control in an intraoperative setting and in the intensive care unit did not differentially affect clinical outcomes 21 . A study about neonates TGC was unreliable due to small sample and severe hypoglycaemia 22 .
Some research has confirmed that hypoglycaemia is a cause of severe neurologic morbidity and even mortality 10,23-25 , but our analysis found that perioperative hypoglycaemia was not an independent risk factor for adverse outcomes. However, only a small number of infants experienced transient hypoglycaemia (minimum glucose below 3.6 mmol/l) while most low blood glucoses recovered in a very short time. This must also be considered when interpreting our results. Glucose solution may not be urgent when blood glucose levels decrease below 3.6 mmol/l. However, we cannot comment on when glucose should be administered at lower blood glucose levels.
There are no standards for defining either hyperglycaemia or hypoglycaemia among critically ill children. In a retrospective analysis, authors indicated that a blood glucose >8.3 mmol/l was associated with increased mortality, nosocomial infections and increased hospital length-of-stay 3 . Numerous PICU clinicians also considered that the average threshold to define hyperglycaemia was 8.3 mmol/l 26 , and it may not be necessary to use TGC to maintain glucose levels below 8.3 mmol/l 27 ; therefore we decided to use 8.3 mmol/l as the threshold to define hyperglycaemia. We chose to define hypoglycaemia as a blood glucose concentration of <3.6 mmol/l due to a recent study pointing out that this level was associated with increased morbidity and mortality rates 25 . From a biochemical standpoint, counter-regulatory hormones were activated at levels between 3.6 and 3.8 mmol/l for paediatric patients 24 .
Compared with previous similar studies 6,16-17 , our study collected and analysed data from the preoperative, intraoperative and postoperative periods, and included more potential risk factors which is pivotal in retrospective studies. In addition, the sample of 233 patients was larger than in many previous studies.
CONCLUSION
In conclusion, we found that, compared to the preoperative period, blood glucose values increased considerably during and after surgery. However, we found no obvious association between abnormal perioperative glucose levels and adverse outcomes in infants having open-heart surgery with CPB for congenital heart disease. Owing to the inherent limitations of this retrospective study, further randomised controlled clinical trials are needed.
